Adirondack Trust Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,122
| Closed | -$116K | – | 484 |
|
|
2022
Q2 | $116K | Buy |
2,122
+110
| +5% | +$6.07K | 0.06% | 145 |
|
|
2022
Q1 | $110K | Buy |
2,012
+1,284
| +176% | +$69.7K | 0.05% | 157 |
|
|
2021
Q4 | $40K | Sell |
728
-48
| -6% | -$2.5K | 0.02% | 195 |
|
|
2021
Q3 | $41K | Hold |
776
| – | – | 0.02% | 202 |
|
|
2021
Q2 | $39K | Hold |
776
| – | – | 0.02% | 205 |
|
|
2021
Q1 | $34K | Hold |
776
| – | – | 0.02% | 210 |
|
|
2020
Q4 | $36K | Sell |
776
-128
| -14% | -$5.88K | 0.02% | 197 |
|
|
2020
Q3 | $42K | Hold |
904
| – | – | 0.03% | 167 |
|
|
2020
Q2 | $45K | Hold |
904
| – | – | 0.03% | 166 |
|
|
2020
Q1 | $43K | Sell |
904
-484
| -35% | -$25.8K | 0.04% | 158 |
|
|
2019
Q4 | $81K | Buy |
1,388
+984
| +244% | +$54.7K | 0.05% | 154 |
|
|
2019
Q3 | $21K | Buy |
404
+84
| +26% | +$4.32K | 0.01% | 212 |
|
|
2019
Q2 | $16K | Hold |
320
| – | – | 0.01% | 231 |
|
|
2019
Q1 | $16K | Hold |
320
| – | – | 0.01% | 216 |
|
|
2018
Q4 | $15K | Hold |
320
| – | – | 0.01% | 218 |
|
|
2018
Q3 | $16K | Hold |
320
| – | – | 0.01% | 223 |
|
|
2018
Q2 | $16K | Hold |
320
| – | – | 0.01% | 216 |
|
|
2018
Q1 | $16K | Sell |
320
-180
| -36% | -$8.38K | 0.01% | 217 |
|
|
2017
Q4 | $22K | Sell |
500
-40
| -7% | -$1.85K | 0.02% | 193 |
|
|
2017
Q3 | $27K | Hold |
540
| – | – | 0.02% | 184 |
|
|
2017
Q2 | $29K | Buy |
540
+100
| +23% | +$5.33K | 0.02% | 179 |
|
|
2017
Q1 | $23K | Buy |
440
+40
| +10% | +$2.03K | 0.02% | 205 |
|
|
2016
Q4 | $19K | Buy |
400
+40
| +11% | +$1.98K | 0.01% | 212 |
|
|
2016
Q3 | $19K | Buy |
360
+40
| +13% | +$2.19K | 0.01% | 208 |
|
|
2016
Q2 | $17K | Hold |
320
| – | – | 0.01% | 240 |
|
|
2016
Q1 | $16K | Hold |
320
| – | – | 0.01% | 222 |
|
|
2015
Q4 | $17K | Hold |
320
| – | – | 0.01% | 212 |
|
|
2015
Q3 | $15K | Hold |
320
| – | – | 0.01% | 214 |
|
|
2015
Q2 | $17K | Sell |
320
-100
| -24% | -$5.63K | 0.01% | 215 |
|
|
2015
Q1 | $24K | Buy |
420
+100
| +31% | +$5.73K | 0.02% | 206 |
|
|
2014
Q4 | $17K | Hold |
320
| – | – | 0.01% | 220 |
|
|
2014
Q3 | $18K | Hold |
320
| – | – | 0.01% | 222 |
|
|
2014
Q2 | $21K | Hold |
320
| – | – | 0.02% | 208 |
|
|
2014
Q1 | $21K | Hold |
320
| – | – | 0.02% | 195 |
|
|
2013
Q4 | $21K | Hold |
320
| – | – | 0.02% | 187 |
|
|
2013
Q3 | $20K | Hold |
320
| – | – | 0.02% | 188 |
|
|
2013
Q2 | $20K | Buy |
+320
| New | +$20.3K | 0.02% | 173 |
|
Other funds holding GSK
Adirondack Trust Company's GSK Position: Q3 2022 in Review
Adirondack Trust Company sold out of GSK (GSK) in Q3 2022, closing a stake of 2,122 shares — an estimated $116K sold.
Adirondack Trust Company first reported a position in GSK in Q2 2013 and held it in 37 quarters. The position peaked at $116K in Q2 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.
- Adirondack Trust Company reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
- Adirondack Trust Company sold 2,122 GSK shares in Q3 2022, an estimated $116K.
- Adirondack Trust Company first reported a position in GSK in Q2 2013 and held it in 37 quarters.
- Adirondack Trust Company's GSK position peaked at $116K in Q2 2022.
- 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.
Based on Adirondack Trust Company's 13F filing for Q3 2022, filed 13 Oct 2022.